1y2d: Difference between revisions

New page: left|200px<br /> <applet load="1y2d" size="450" color="white" frame="true" align="right" spinBox="true" caption="1y2d, resolution 1.70Å" /> '''Catalytic Domain Of...
 
No edit summary
Line 1: Line 1:
[[Image:1y2d.gif|left|200px]]<br />
[[Image:1y2d.gif|left|200px]]<br /><applet load="1y2d" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1y2d" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1y2d, resolution 1.70&Aring;" />
caption="1y2d, resolution 1.70&Aring;" />
'''Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-methoxy-phenyl)-3,5-dimethyl-1H-pyrazole-4-carboxylic acid ethyl ester'''<br />
'''Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-methoxy-phenyl)-3,5-dimethyl-1H-pyrazole-4-carboxylic acid ethyl ester'''<br />


==Overview==
==Overview==
Cyclic nucleotide phosphodiesterases (PDEs) comprise a large family of, enzymes that regulate a variety of cellular processes. We describe a, family of potent PDE4 inhibitors discovered using an efficient method for, scaffold-based drug design. This method involves an iterative approach, starting with low-affinity screening of compounds followed by, high-throughput cocrystallography to reveal the molecular basis underlying, the activity of the newly identified compounds. Through detailed, structural analysis of the interaction of the initially discovered, pyrazole carboxylic ester scaffold with PDE4D using X-ray crystallography, we identified three sites of chemical substitution and designed small, selective libraries of scaffold derivatives with modifications at these, sites. A 4,000-fold increase in the potency of this PDE4 inhibitor was, achieved after only two rounds of chemical synthesis and the structural, analysis of seven pyrazole derivatives bound to PDE4B or PDE4D, revealing, the robustness of this approach for identifying new inhibitors that can be, further developed into drug candidates.
Cyclic nucleotide phosphodiesterases (PDEs) comprise a large family of enzymes that regulate a variety of cellular processes. We describe a family of potent PDE4 inhibitors discovered using an efficient method for scaffold-based drug design. This method involves an iterative approach starting with low-affinity screening of compounds followed by high-throughput cocrystallography to reveal the molecular basis underlying the activity of the newly identified compounds. Through detailed structural analysis of the interaction of the initially discovered pyrazole carboxylic ester scaffold with PDE4D using X-ray crystallography, we identified three sites of chemical substitution and designed small selective libraries of scaffold derivatives with modifications at these sites. A 4,000-fold increase in the potency of this PDE4 inhibitor was achieved after only two rounds of chemical synthesis and the structural analysis of seven pyrazole derivatives bound to PDE4B or PDE4D, revealing the robustness of this approach for identifying new inhibitors that can be further developed into drug candidates.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1Y2D is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ZN, MG, 4DE, EDO and B3P as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/3',5'-cyclic-nucleotide_phosphodiesterase 3',5'-cyclic-nucleotide phosphodiesterase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.4.17 3.1.4.17] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1Y2D OCA].  
1Y2D is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=MG:'>MG</scene>, <scene name='pdbligand=4DE:'>4DE</scene>, <scene name='pdbligand=EDO:'>EDO</scene> and <scene name='pdbligand=B3P:'>B3P</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/3',5'-cyclic-nucleotide_phosphodiesterase 3',5'-cyclic-nucleotide phosphodiesterase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.4.17 3.1.4.17] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Y2D OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Artis, D.R.]]
[[Category: Artis, D R.]]
[[Category: Blasdel, L.]]
[[Category: Blasdel, L.]]
[[Category: Bollag, G.]]
[[Category: Bollag, G.]]
[[Category: Card, G.L.]]
[[Category: Card, G L.]]
[[Category: England, B.P.]]
[[Category: England, B P.]]
[[Category: Fong, D.]]
[[Category: Fong, D.]]
[[Category: Gillette, S.]]
[[Category: Gillette, S.]]
[[Category: Ibrahim, P.N.]]
[[Category: Ibrahim, P N.]]
[[Category: Kim, S.H.]]
[[Category: Kim, S H.]]
[[Category: Milburn, M.V.]]
[[Category: Milburn, M V.]]
[[Category: Schlessinger, J.]]
[[Category: Schlessinger, J.]]
[[Category: Suzuki, Y.]]
[[Category: Suzuki, Y.]]
[[Category: Zhang, C.]]
[[Category: Zhang, C.]]
[[Category: Zhang, K.Y.J.]]
[[Category: Zhang, K Y.J.]]
[[Category: 4DE]]
[[Category: 4DE]]
[[Category: B3P]]
[[Category: B3P]]
Line 42: Line 41:
[[Category: pyrazole]]
[[Category: pyrazole]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:13:54 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:01:08 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA